<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02088346</url>
  </required_header>
  <id_info>
    <org_study_id>Xijing-Tele-001</org_study_id>
    <nct_id>NCT02088346</nct_id>
  </id_info>
  <brief_title>Acute Stroke Advancing Program Using Telemedicine</brief_title>
  <acronym>ASAP-Tel</acronym>
  <official_title>Intravenous Thrombolysis Guided by Telemedicine Consultation System for Acute Ischemic Stroke Patients in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Department of Science and Technology of Shanxi Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fourth Military Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to evaluate the effectiveness and safety profile of telemedicine consultation
      system in making decision on IV thrombolysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The rate of intravenous thrombolysis with tissue-type plasminogen activator or urokinase for
      stroke patients was extremely low in China. It has been demonstrated that telestroke may help
      to increase the rate of intravenous thrombolysis and improve the stroke care quality in the
      local hospitals. The aim of this study is to evaluate the effectiveness and safety of
      decision making of intravenous thrombolysis via telemedicine consultation system for acute
      ischemic stroke patients in China This trial network consists of one hub hospital (Xijing
      Hospital) and 14 spoke hospitals in the remote area of Shanxi Province. The telemedicine
      consultation system is an interactive, 2-way, wireless, audiovisual system based on portable
      hardwares--tablet computer or smartphone. Before this study, we have been investigating the
      usual stroke care quality in the spoke hospitals without the guidance from the hub hospital,
      which will be used as the historical control of this study. After that, the teleconsultation
      system will be introduced.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients treated with intravenous thrombolysis</measure>
    <time_frame>at 4.5 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Favorite outcome at 3 months (modified Rankin score â‰¤2)</measure>
    <time_frame>at 1 month/3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke complications</measure>
    <time_frame>at 24 hours/7days</time_frame>
    <description>They include symptomatic intracranial hemorrhage (sICH), symptomatic cerebral edema from an original brain infarction, cerebral hernia, seizure, severe extracranial bleeding, pulmonary embolism, pulmonary edema, deep venous thrombosis, and sepsis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatal and nonfatal cardiovascular events</measure>
    <time_frame>at 7 days</time_frame>
    <description>They include recurrent ischemic stroke, intracranial hemorrhage, subarachnoid hemorrhage, transient ischemic attack, myocardial infarction, angina and heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>at 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time intervals</measure>
    <time_frame>at 24 hours</time_frame>
    <description>Those from stroke onset to arriving in emergency department(ED), and from arriving in ED to physician/CT initiation/CT interpretation/specific treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>at 3 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Teleconsultation</arm_group_label>
    <description>Intravenous thrombolysis guided by telemedicine consultation system based on portable hardwares</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Historical control</arm_group_label>
    <description>Usual stroke care without the guidance from hub hospital</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telemedicine consultation system</intervention_name>
    <description>Telemedicine consultation system based on portable hardwares</description>
    <arm_group_label>Teleconsultation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Ischemic stroke patients arriving in the local hospitals within 4.5 hours of symptom onset
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years and less than 80 years

          -  Acute ischemic stroke

          -  Presenting to Emergency Department of spoke hospitals within 4.5 hours of stroke
             symptom onset

          -  National Institutes of Health Stroke Scale (NIHSS) between 4 and 25

          -  Signed consent form by the patient or his relatives

        Exclusion Criteria:

          -  Time of symptom onset unclear

          -  Unlikely to complete study through 3-month follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhirong Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xijing Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gang Zhao, MD</last_name>
    <role>Study Director</role>
    <affiliation>Xijing Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ziwen Yuan, MD</last_name>
    <email>yuan0929rong@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhirong Liu, MD</last_name>
    <email>liuzhir@fmmu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xingyuan Hospital</name>
      <address>
        <city>Yulin</city>
        <state>Shanxi</state>
        <zip>719000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yulin First People's Hospital</name>
      <address>
        <city>Yulin</city>
        <state>Shanxi</state>
        <zip>719000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yulin Second People's Hospital</name>
      <address>
        <city>Yulin</city>
        <state>Shanxi</state>
        <zip>719000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yuyang District People's Hospital</name>
      <address>
        <city>Yulin</city>
        <state>Shanxi</state>
        <zip>719000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2014</study_first_submitted>
  <study_first_submitted_qc>March 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2014</study_first_posted>
  <last_update_submitted>June 23, 2015</last_update_submitted>
  <last_update_submitted_qc>June 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Thrombolysis</keyword>
  <keyword>Tissue plasminogen activator</keyword>
  <keyword>Urokinase</keyword>
  <keyword>Telemedicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

